The FDA Approved A Blood Test To Predict Preeclampsia

The test helps determine those patients' risks of developing Preeclampsia by measuring the balance of two proteins in the blood.

The FDA has approved a blood test for Preeclampsia.

The condition is a blood-pressure disease that occurs when a person develops high blood pressure after 20 weeks of pregnancy. It is a leading cause of maternal death and disability world wide.

The ‘Per Thermo Fisher Scientific’ test is designed to be given to pregnant people who have been hospitalized for blood pressure disorders. It helps determine those patients’ risks of developing Preeclampsia by measuring the balance of two proteins in the blood. The wider the ratio of those proteins, the greater likelihood that patient has of developing severe Preeclampsia.

There is no cure for the condition, but there are medications that assist in lowering a persons blood pressure and the new test could assist in pre-detecting a person’s possibility of getting Preeclampsia while pregnant.